[1] |
XIE Jinfang , CAO Chunyu , REN Xue , TIAN Jiajun , LÜ Yafeng , HUANG Xiaofei .
Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells
[J]. China Oncology, 2021, 31(7): 605-615.
|
[2] |
YANG Jia , LIU Shuyuan , WANG Yingying , LI Yingfu , MA Qianli , LI Yu , WANG Yongrong , LI Chuanyin , TAN Fang .
The association of polymorphisms in TNF-α gene with non-small cell lung cancer in Han population of Yunnan Province
[J]. China Oncology, 2021, 31(7): 616-628.
|
[3] |
ZHANG Jian , SHEN Weina , JI Dongmei , WANG Leiping , GONG Chengcheng , HU Xichun .
FUSCC criteria for the management of targeted drug-induced interstitial lung disease in solid tumors
[J]. China Oncology, 2021, 31(4): 241-249.
|
[4] |
LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang .
Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
[J]. China Oncology, 2021, 31(4): 350-360.
|
[5] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[6] |
LI Zhijun, XU Binghe.
Research progress of resistance to aromatase inhibitor therapy in breast cancer
[J]. China Oncology, 2021, 31(2): 81-89.
|
[7] |
WU Chunxiao , GU Kai , PANG Yi , BAO Pingping , WANG Chunfang , SHI Liang , GONG Yangming , XIANG Yongmei , DOU Jianming , SHI Yan , FU Chen .
Analysis of the current status of cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016
[J]. China Oncology, 2021, 31(10): 879-891.
|
[8] |
JIANG Mengyi , LU Yanqiao , WANG Hongxia .
Research progress and clinical significance of breast cancer heterogeneity
[J]. China Oncology, 2020, 30(5): 394-400.
|
[9] |
SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng .
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
[J]. China Oncology, 2020, 30(3): 186-191.
|
[10] |
ZHU Xiaojian, LIN Kang, BU Fanqin, LUO Chen, HUANG Chao, ZHU Zhengming.
High expression of DJ-1 promotes growth and invasion of colorectal cancer cells via the cyclin D1/p53-MDM2-AKT signaling pathway
[J]. China Oncology, 2020, 30(3): 208-216.
|
[11] |
YU Mei,MEI Qi,HAN Yingying,ZHAI Lingyun,SHA Hongfang,XU Xiangyong,NI Juan,CUI Jianwei,DING Hong .
Value of contrast-enhanced ultrasound in monitoring liver cirrhotic and dysplastic nodules and early diagnosis of hepatocellular carcinomas
[J]. China Oncology, 2019, 29(9): 709-714.
|
[12] |
ZHAO Yudi, TAN Fang, YAN Zhiling, LI Yingfu, DAI Shuying, ZHOU Ziyun, ZHANG Xinwen, LIU Shuyuan, SHI Li, YAO Yufeng.
Correlation between genetic variants in CD44 gene and cervical cancer and non-small cell lung cancer
[J]. China Oncology, 2019, 29(4): 277-283.
|
[13] |
CAO Xiaoshan, CONG Binbin.
The progress of treatment for triple-negative breast cancer in the era of precision medicine
[J]. China Oncology, 2019, 29(12): 971-976.
|
[14] |
ZHENG Xiaying, CHEN Junxia.
Expression of circRNA hsa_circ_0005320 in triple-negative breast cancer and its effect on cell proliferation
[J]. China Oncology, 2019, 29(11): 845-854.
|
[15] |
ZHU Xiuzhi, CHEN Li, JI Lei, GAO Yu, WANG Zhonghua.
Advances in the treatment of triple-negative breast cancer with CDK4/6 inhibitors
[J]. China Oncology, 2019, 29(11): 899-905.
|